换一批
换一批The impact of upfront versus sequential use of bortezomib among patients with newly diagnosed multiple myeloma (MM): a joint analysis of the Singapore MM Study Group and the Korean MM Working Party for the Asian myeloma network.
作者：
主题词
成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);硼酸化物(Boronic Acids);用药计划表(Drug Administration Schedule);女(雌)性(Female);随访研究(Follow-Up Studies);人类(Humans);男(雄)性(Male);中年人(Middle Aged);多发性骨髓瘤(Multiple Myeloma);肿瘤复发, 局部(Neoplasm Recurrence, Local);预后(Prognosis);吡嗪类(Pyrazines);缓解诱导(Remission Induction);韩国(Republic of Korea);新加坡(Singapore);存活率(Survival Rate);沙立度胺(Thalidomide)
DOI
10.1016/j.leukres.2013.06.008
PMID
23816344
发布时间
2018-12-02
- 浏览73
Leukemia research
1070-6页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
